Abstract
BackgroundIn continuation of our work, new diazenyl chalcones scaffolds (C-18 to C-27) were efficiently synthesized from substituted acetophenone azo dyes (A–E) by base catalyzed Claisen–Schmidt condensation with different substituted aromatic/heteroaromatic aldehydes.MethodologyThe synthesized chalcones were assessed for their in vitro antimicrobial potential towards several pathogenic microbial strains by tube dilution method and further evaluated for antioxidant potential by DPPH assay. These derivatives were also assessed for the cytotoxicity towards the human lung cancer cell line (A549) and normal cell line (HEK) by MTT assay. The most active antimicrobial compounds were docked using Schrodinger v18.1 software with the various potential bacterial receptors to explore the mechanism of interaction.ResultsThe derivative C-22 exhibited high antibacterial activity with very low MIC (1.95–3.90 µg ml−1) and MBC (3.90–7.81 µg ml−1) values. The derivatives C-23, C-24 and C-27 have demonstrated good antioxidant potential (IC50 = 7–18 µg ml−1) correlated to the ascorbic acid (IC50 = 4.45 µg ml−1). The derivative C-25 had shown comparable cytotoxicity to camptothecin against A549 cell line. The docking studies predicted the bacterial dihydrofolate reductase (PDB ID: 3SRW) and bacterial DNA gyrase (PDB ID: 4ZVI) as the possible targets for most of the active antimicrobial compounds. These derivatives affirmed their safety by presenting less cytotoxicity towards HEK cells. Further the ADME prediction by qikprop module of the Schrodinger proved that these compounds exhibited drug-like attributes.ConclusionHence, these compounds have shown their potential as lead for future expansion of novel antimicrobial and cytotoxic drugs.
Highlights
The use of antimicrobial agents in clinical practice is one of the remarkable achievements of modern medicine
In the light of above facts, we further extend our synthesis to some novel diazenyl chalcones and evaluation of their antimicrobial, antioxidant and cytotoxic potential against lung cancer cell line (A549) and safety study against normal cell line (HEK 293)
The diazenyl chalcones (C18–C27 were synthesized by the Claisen–Schmidt condensation of the α-methyl group present in azo dye with aldehyde group present in various reactants in the presence of alkali solution (Scheme 1)
Summary
The use of antimicrobial agents in clinical practice is one of the remarkable achievements of modern medicine. The emergence of new strains of microorganisms is contributing to the observed resistance to the antimicrobial compounds [6, 7]. This spread of resistance has restricted the treatment alternatives for some severe and life-threatening infectious disorders [8, 9]. Most of the patients with lung cancer have already developed metastatic disease, at the time of diagnosis, limiting the use of another therapeutic option, such as radiation and surgery. The current drugs used for the treatment of lung cancers have developed resistance, conferred the limited treatment scope [15, 16]. In continuation of our work, new diazenyl chalcones scaffolds (C-18 to C-27) were efficiently synthesized from substituted acetophenone azo dyes (A–E) by base catalyzed Claisen–Schmidt condensation with different substituted aromatic/heteroaromatic aldehydes
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have